Skip to main content

Allovir Inc(ALVR-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low0.7400
Day High0.7800
Open:0.7600
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
TheNewswire.com
ALVR DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR
TheNewswire.com
ALVR DEADLINE: ROSEN, A RANKED AND LEADING FIRM, Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ALVR DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ALVR DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ALVR DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR
TheNewswire.com
Holzer & Holzer, LLC Reminds Shareholders of the March 19, 2024 Lead Plaintiff Deadline in the AlloVir, Inc. (ALVR) Class Action - Nationally Ranked Investors Rights Firm Encourages Investors With Significant Losses to Contact the Firm
TheNewswire.com
ALVR DEADLINE NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR
TheNewswire.com
ALVR IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, NATIONAL TRIAL COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, A TOP RANKED LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, A LONGSTANDING LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages AlloVir, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, NATIONAL TRIAL COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, NATIONAL TRIAL COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AlloVir, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, A RANKED AND LEADING FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, NATIONAL TRIAL LAWYERS, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
TheNewswire.com
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
MarketBeat
MarketBeat Week in Review โ€“ 7/10 - 7/14

Profile

AlloVir, Inc. is a late clinical-stage cell therapy company which focus on restoring natural immunity against life-threatening viral diseases. AlloVir, Inc. is based in CAMBRIDGE, Mass.